Maddalena de Virgilio | Biological Sciences | Innovative Research Award

Published on by Award and Honors

Dr. Maddalena de Virgilio | Biological Sciences | Innovative Research Award

Dr. Maddalena de Virgilio | National Research Council | Italy

Dr. Maria de Virgilio is a distinguished Italian molecular biologist recognized for her contributions to plant biochemistry, cellular signaling, and marine biodiversity genomics. she has advanced understanding of molecular processes in plants and marine ecosystems through interdisciplinary biotechnology. Her work connects agricultural biotechnology with environmental genomics, incorporating molecular biology, data analytics, and citizen science. Collaborating across Europe and the USA, she has published extensively on protein quality control, ER-associated degradation, and genetic monitoring of marine species. With 1,271 citations across 1,143 documents and 22 scientific publications, her research demonstrates strong international impact. Her career exemplifies scientific leadership and a deep commitment to advancing biotechnology for ecological preservation and sustainable development through collaborative, data-driven, and environmentally conscious approaches.

Profile : Scopus 

Featured Publications

De Virgilio, M., et al. (2025). DNA barcoding and nutritional analysis of anchovies. Genes. DOI:10.3390/genes16101219

De Paola, D., Chimienti, G., Degryse, B., & De Virgilio, M. (2024). Genetic structure of Posidonia oceanica meadows. Journal for Nature Conservation. DOI:10.1016/j.jnc.2024.126585

De Virgilio, M., et al. (2021). Citizen science in monitoring Ostreopsis ovata blooms. Marine Pollution Bulletin. DOI:10.1016/j.marpolbul.2021.112981

Foresti, O., De Marchis, F., & De Virgilio, M. (2008). Protein domains and quality control in plants. Molecular Plant. DOI:10.1093/mp/ssn066

Hassan Dianat-Moghadam | Molecular Biology | Best Researcher Award

Published on by Award and Honors

Assist. Prof. Dr. Hassan Dianat-Moghadam | Molecular Biology | Best Researcher Award

Isfahan University of Medical Sciences | Iran

Dr. Hassan Dianat-Moghadam is an Assistant Professor in the Department of Genetics and Molecular Biology at the School of Medicine, Isfahan University of Medical Sciences, with a joint appointment at the Pediatric Inherited Diseases Research Center. His expertise spans molecular biology, genetics, immunotherapy, and medical biotechnology, with particular emphasis on cancer biology and parasitic diseases. He began his academic journey with a diploma and undergraduate studies in Laboratory Sciences, followed by a Master’s and Ph.D. in Medical Biotechnology, where he focused on translational research in genetics and molecular medicine. His career integrates clinical, research, and teaching roles, beginning as a laboratory technician in microbiology and hematology and advancing to academia, where he has guided undergraduate, master’s, and doctoral students in genetics, biotechnology, and cancer research. His research focuses on cancer resistance mechanisms, immunotherapies targeting tumor vasculature, live attenuated vaccines, nanoparticle-based treatments, wound healing technologies, and gene therapy applications, aiming to connect laboratory discoveries with clinical outcomes. Recognized for his impactful research, funded projects, and contributions to international journals, he has earned global recognition with 1,132 citations by 976 documents, 49 published documents, and an h-index of 20. He has also been acknowledged for his mentorship and commitment to academic excellence. His achievements underscore his ability to bridge fundamental science with applied biotechnology, advancing solutions in regenerative medicine, infectious disease, and cancer therapy, while shaping the next generation of biomedical researchers.

Profile : Scopus | ORCID | Google Scholar 

Featured Publication 

Dianat-Moghadam, H., et al. (n.d.). Immunotherapies targeting tumor vasculatures: Challenges and opportunities. Frontiers in Immunology.

Dianat-Moghadam, H., et al. (n.d.). Exosome-mediated drug resistance in cancer: Molecular mechanisms and clinical applications. Molecular Cancer.

Dianat-Moghadam, H., et al. (n.d.). Therapeutic strategies against Leishmania major. Parasite Immunology.